APA (7th ed.) Citation

HZ, H., YJ, W., JR, C., H, M., HX, G., QC, D., & BJ, S. (2023). Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris. American journal of therapeutics, 30(6), e544. https://doi.org/10.1097/MJT.0000000000001620

Chicago Style (17th ed.) Citation

HZ, Hui, Wang YJ, Cheng JR, Mao H, Guo HX, Diao QC, and Shi BJ. "Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris." American Journal of Therapeutics 30, no. 6 (2023): e544. https://doi.org/10.1097/MJT.0000000000001620.

MLA (9th ed.) Citation

HZ, Hui, et al. "Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris." American Journal of Therapeutics, vol. 30, no. 6, 2023, p. e544, https://doi.org/10.1097/MJT.0000000000001620.